Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
ALLERGAN, INC. et al v. HI-TECH PHARMACAL CO., INC.
Case Number:
1:11-cv-00650
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
-
April 23, 2013
Allergan, Duke Block Lash-Growth Generics
A North Carolina federal judge on Tuesday granted a permanent injunction to Allergan Inc. and Duke University against several planned generic versions of eyelash growth stimulant Latisse after previously finding the proposed drugs infringed on two patents, disregarding the protests of the generic-drug makers.
-
January 30, 2013
Allergan, Duke Get Generic Lash-Growth Treatments Blocked
A North Carolina federal judge has blocked the release of generic versions of Allergan Inc. and Duke University's Latisse eyelash growth stimulant, ruling three generics makers had infringed two Allergan and Duke patents.
-
August 18, 2011
Allergan Sues Again To Block Generic Latisse
Allergan Inc. filed a patent infringement suit against Hi-Tech Pharmacal Co. Inc. in North Carolina on Wednesday in its latest effort to block a generic version of the eyelash growth treatment Latisse.